RGC 5.09 Regencell Bioscience Holdings Limited
| Range: | 3.03-32.44 | Vol Avg: | 213098 | Last Div: | 0 | Changes: | -0.1 |
| Beta: | -0.58 | Cap: | 0.07B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Jul 16 2021 | Empoloyees: | 12 | ||
| CUSIP: | G7487R100 | CIK: | 0001829667 | ISIN: | KYG7487R1002 | Country: | HK |
| CEO: | Mr. Yat-Gai Au | Website: | https://www.regencellbioscience.com | ||||
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow